๐ง Hypertonic Saline or Mannitol for Cerebral Edema?
Cerebral edema and intracranial hypertension remain among the most common life-threatening problems in neurocritical care. The Neurocritical Care Society guideline provides several practical bedside recommendations.
๐น Hypertonic saline (HTS) is generally preferred over mannitol for acute ICP control in TBI and intracerebral hemorrhage due to more reliable and sustained ICP reduction.
๐น Both HTS and mannitol effectively reduce ICP, but neither has consistently demonstrated improved long-term neurological outcomes.
๐น In subarachnoid hemorrhage, symptom-triggered HTS boluses are favored over targeting a specific serum sodium concentration.
๐น In acute ischemic stroke, either HTS or mannitol may be used, but routine prophylactic mannitol administration is discouraged.
๐น Corticosteroids should not be used for intracerebral hemorrhage, as evidence suggests no benefit and potential harm.
๐น The major exception is bacterial meningitis, where dexamethasone reduces neurological sequelae and should be administered before or with the first antibiotic dose.
โ ๏ธ Safety matters. Severe hypernatremia (>155โ160 mEq/L) and hyperchloremia (>110โ115 mEq/L) are associated with increased risk of acute kidney injury and require close monitoring.
Take-home message: Hyperosmolar therapy remains a cornerstone of cerebral edema management, but treatment should be individualized according to the underlying neurological pathology rather than pursuing arbitrary sodium targets.
#NeurocriticalCare #ICU #CriticalCare #TBI #Stroke #SAH #ICH #CerebralEdema #HypertonicSaline #Mannitol #NeuroICU
Reference ๐
Cook AM, Jones GM, Hawryluk GWJ, et al. Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients. Neurocrit Care. 2020;32:647-666. DOI: 10.1007/s12028-020-00959-7.
ALT